Full Library
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience
Resource type
Journal Article
Authors/contributors
- Lu, Brian (Author)
- Ha, David (Author)
- Shen, Sa (Author)
- Ferguson Toll, Jessica (Author)
- Kim, Ailin (Author)
- Kim, Sarah (Author)
- Mui, Emily (Author)
- Deresinski, Stan (Author)
- Holubar, Marisa (Author)
- Alegria, William (Author)
Title
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience
Abstract
Abstract
Combination antifungal therapy for invasive mucormycosis remains controversial and is inconsistently defined in prior studies. In a cohort of immunocompromised patients with invasive mucormycosis, we found no difference in 6-week mortality with upfront nor salvage combination therapy compared to monotherapy.
Publication
Open Forum Infectious Diseases
Date
2024-02-22
Pages
ofae103
Accessed
3/10/24, 5:18 PM
ISSN
2328-8957
Short Title
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Lu, B., Ha, D., Shen, S., Ferguson Toll, J., Kim, A., Kim, S., Mui, E., Deresinski, S., Holubar, M., & Alegria, W. (2024). Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience. Open Forum Infectious Diseases, ofae103. https://doi.org/10.1093/ofid/ofae103
ORGANISMS
Link to this record